期刊文献+

毛蕊异黄酮葡萄糖苷自微乳给药系统的制备及质量控制 被引量:1

Study on Self-Microemulsifying Drug Delivery System of Calycosin-7-glucoside and Quality Evaluation
下载PDF
导出
摘要 目的:制备毛蕊异黄酮苷自微乳给药系统并建立其质量评价方法。方法:以乳化剂OP-10、聚氧乙烯醚(40)和二乙二醇单乙基醚制备毛蕊异黄酮苷自微乳给药系统,考察其外观、粒径分布、Zeta电位及稳定性;采用高效液相色谱法建立毛蕊异黄酮苷自微乳的质量评价方法。结果:所得自微乳稳定性良好,平均粒径为32.21 nm,电动电势为-19.43 m V(n=3)。毛蕊异黄酮苷的进样量在0.207~3.105μg范围内具有良好的线性关系,平均回收率为99.90%(n=9),RSD=0.79%。结论:该制剂制备工艺简便,质量稳定可控,符合良好的自微乳制剂的要求。 OBJECTIVE: To establish the self-Microemulsifying drug delivery system of calycosin-7-glucoside and quality evaluation method. METHODS: The Calycosin-7-glucoside-SMEDDS was prepared with OP-10 emulsifier,Cremophor RH40 and Transcutol P,and the appearance,size distribution,Zeta potential and stability were examined.The contents of Calycosin-7-glucosidecwas determined by HPLC. RESULTS: The Calycosin-7-glucoside-SMEDDSwas stable,the average particle size and Zeta potential were 32. 21 nm and-19. 43 m V( n = 3),respectively. The linear ranges of Stanozolol was 0. 207 μg-3. 105 μg. The average recovery of Trenbolone Acetate was 99. 90%( n = 9),RSD = 0. 79%. CONCLUSIONS: The preparation technique of the microemulsion is simple and feasible,and the quality is stable and controllable,which meets the needs of good SMEDDS formulation.
出处 《中国医院用药评价与分析》 2017年第7期885-888,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
基金 澳门科学技术发展基金(No.049/2012/A2)
关键词 毛蕊异黄酮葡萄糖苷 自微乳给药系统 质量评价 Calycosin-7-glucoside Self microemulsifying drug delivery system Quality evaluation
  • 相关文献

参考文献13

二级参考文献109

共引文献141

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部